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Background
Smoking or chewing tobacco and alcohol consumption
are the major risk factors for development of Head and
Neck Squamous Cell Carcinoma (HNSCC). However,
studies suggest that a subset of these cancers could be
associated with HPV infections. This association is rein-
forced by the fact that the most prevalent HPV types found
in cervical carcinoma are those most frequently detected
in Head and Neck Cancer. The prevalence of HPV in this
type of cancer is highly variable with detection rates vary-
ing from 0 to 100% depending on the study and the ana-
tomic location of the neoplasm. Few studies have been
made in Mexican populations to determine prevalence of
HPV in HNSCC. The aim of this study is to determine the
prevalence of HPV in samples of patients with HNSCC
and healthy individuals in a Mexican Population and to
establish the types of HPV and HPV16 variants present in
these samples.
Materials and methods
We conducted a case-control study in 100 samples of
HNSCC and 100 control subjects. DNA from samples of
exfoliated cells and biopsies was extracted using the salt-
ing out method, amplification of β-globin gene by PCR
was used to asses DNA quality. HPV presence was evalu-
ated by PCR with MY09/MY11 and GP5+/GP6+ primers.
DNA sequencing was used to determine HPV types and
variant types.
Results
So far we had evaluated 50 samples of case patients, 46
were β-globin positive. HPV was detected in 72% (33/46)
of the samples; 61.5% of carcinomas of the oral cavity,
74% of larynx and 100% of oropharynx. HPV type 16 was
the most prevalent one (47%). Some variants of HPV type
16 have been determined and European (E) variants had
been the most frequent ones.
Conclusion
HPV DNA was found in a high percentage of HNSCCs.
HPV may preferentially infect certain anatomic sites of the
Head and Neck because prevalence was greater in the sam-
ples of the oropharynx than any other site, although anal-
ysis of a greater number of samples is needed to confirm
these observations. As previously documented for Cervi-
cal Cancer, the most frequent type found was HPV type 16
and the variant type was European (E).
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